News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Poll Claire
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Sold 20,608 shares
@ $2.539, valued at
$52.3k
Sold 26,352 shares
@ $2.4992, valued at
$65.9k
Sold 1,512 shares
@ $2.4679, valued at
$3.7k
Gifted 89,976 shares
@ $0 Gifted 89,976 shares
@ $0 |
|
08/03/2023 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Sold 18,608 shares
@ $2.679, valued at
$49.9k
Sold 12,944 shares
@ $2.593, valued at
$33.6k
|
|
05/11/2023 |
4/A
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Exercised 8,328 options to buy
@ $0 |
|
05/03/2023 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Sold 80,376 shares
@ $2.5759, valued at
$207k
|
|
02/03/2023 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Gifted 152,000 shares
@ $0 Gifted 152,000 shares
@ $0 Sold 152,000 shares
@ $2.5939, valued at
$394.3k
Exercised 86,272 options to buy
@ $0 Exercised 34,248 options to buy
@ $0 Exercised 58,280 options to buy
@ $0 |
|
09/28/2022 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Granted 800,000 shares
@ $0 |
|
08/03/2022 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Paid exercise price by delivering 79,896 shares
@ $0.6725, valued at
$53.7k
|
|
05/03/2022 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Paid exercise price by delivering 79,896 shares
@ $0.5225, valued at
$41.7k
|
|
11/03/2021 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc
Txns:
| Paid exercise price by delivering 79,896 shares
@ $0.64, valued at
$51.1k
|
|
08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|